Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

A Structural Basis for p53-Deficiency, Deregulated Cell Cycle and Unfavorable Outcome in Diffuse Large B-Cell Lymphoma

Bjoern Chapuy, MD, PhD, Stefano Monti, PhD, Kunihiko Takeyama, MD, PhD, Scott J Rodig, MD, PhD, Yansheng Hao, MD, PhD, Kelly T Yeda, Haig Inguilizian, MD, Craig Mermel, Treeve Currie, Ahmet Dogan, MD, PhD, Jeffery Kutok, MD, PhD, Rameen Beroukhim, MD, PhD, Donna S. Neuberg, ScD, Thomas M Habermann, MD, Gad Getz, PhD, Andrew L. Kung, MD, PhD, Todd R. Golub, MD, Margaret A. Shipp, MD

Blood (2012) 120 (21): 1534.

https://doi.org/10.1182/blood.V120.21.1534.1534

Published: 2012

Journal Articles

Mir-15a/16-1 Cluster Is Frequently Deleted In Primary Hodgkin Lymphoma and Modulates Multiple Survival Pathways Including AP-1

Bjoern Chapuy, MD, PhD, Michael R Green, PhD, Jun Lu, PhD, Stefano Monti, PhD, Yansheng Hao, MD, PhD, Kelly T Yeda, Scott J Rodig, Treeve Currie, Kunihiko Takeyama, MD, PhD, Todd R Golub, MD, PhD, Jeffery Kutok, MD, PhD, Margaret A. Shipp, MD

Blood (2010) 116 (21): 746.

https://doi.org/10.1182/blood.V116.21.746.746

Published: 2010

Journal Articles

Integrative Analysis Reveals Multiple Alterations of p53 Signaling Pathway Components In Primary Diffuse Large B-Cell Lymphomas

Bjoern Chapuy, MD, PhD, Stefano Monti, PhD, Kunihiko Takeyama, MD, PhD, Gad Getz, Scott J Rodig, Jeffery Kutok, MD, PhD, Todd R Golub, Margaret A. Shipp, MD

Blood (2010) 116 (21): 635.

https://doi.org/10.1182/blood.V116.21.635.635

Published: 2010

Journal Articles

Expression and Targeted Inhibition of the Immunoregulatory Carbohydrate-Binding Lectin, Galectin 1, in EBV-Driven Post-Transplant Lymphoproliferative Disorders.

Jing Ouyang, PhD, Przemyslaw Juszczynski, MD, PhD, Evan O'Donnell, Myriam Armant, PhD, Scott J. Rodig, MD, PhD, Kunihiko Takeyama, MD, PhD, Stefano Monti, PhD, Gabriel Rabinovich, PhD, Jeffery Lorne Kutok, MD, PhD, Jerome Ritz, MD, Margaret A. Shipp, MD

Blood (2009) 114 (22): 96.

https://doi.org/10.1182/blood.V114.22.96.96

Published: 2009

Journal Articles

Phase II Study of Chemotherapy (Cx) and Stem Cell Transplantation (SCT) for Adult Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphoma (LBL): Long-Term Follow-up Results of Japan Clinical Oncology Group (JCOG) Study 9402.

Teruhisa Azuma, MD, Kensei Tobinai, MD, PhD, Kunihiko Takeyama, MD, PhD, Taro Shibata, MSc, Haruhiko Fukuda, MD, PhD, Fumio Kawano, MD, PhD, Keiko Aikawa, MD, PhD, Masaharu Kasai, MD, PhD, Takaaki Chou, MD, PhD, Masayuki Sano, MD, PhD, Kuniaki Itoh, MD, PhD, Toshiaki Sai, MD, PhD, Hisashi Yamada, MD, PhD, Kiyoshi Mukai, MD, PhD, Tomomitsu Hotta, MD, PhD, Masanori Shimoyama, MD, PhD

Blood (2009) 114 (22): 3087.

https://doi.org/10.1182/blood.V114.22.3087.3087

Published: 2009

Journal Articles

Selective Expression of the Immunoregulatory Lectin, Galectin-1, in Precursor B Cell Acute Lymphoblastic Leukemias (ALLs) with MLL Rearrangements

Przemyslaw Juszczynski, MD, PhD, Scott J. Rodig, MD, PhD, Kunihiko Takeyama, MD, PhD, Jing Ouyang, PhD, Jorg Faber, MD, PhD, Scott Armstrong, MD, PhD, Jeffery L. Kutok, MD, PhD, Margaret A. Shipp, MD

Blood (2008) 112 (11): 2539.

https://doi.org/10.1182/blood.V112.11.2539.2539

Published: 2008

Journal Articles

Hodgkin’s Lymphoma Reed Sternberg Cells over Express the T-Cell Inhibitory Carbohydrate-Binding Lectin, Galectin 1: Role of AP-1 and Likely Mechanism of Tumor Immune Escape.

Przemyslaw Juszczynski, MD, PhD, Jing Ouyang, PhD, Jeffery L. Kutok, MD, PhD, Stefano Monti, PhD, Wen Chen, MD, Paola Dal Cin, PhD, Jeremy S. Abramson, MD, Kunihiko Takeyama, MD, PhD, Todd R. Golub, MD, Jon C. Aster, MD, PhD, Gabriel A. Rabinovich, PhD, Margaret A. Shipp, MD

Blood (2006) 108 (11): 469.

https://doi.org/10.1182/blood.V108.11.469.469

Published: 2006

Journal Articles

B-Aggressive Lymphoma (BAL) Family Proteins Have Unique Domains Which Modulate Transcription and Exhibit PARP Activity.

Ricardo C.T. Aguiar, MD, PhD, Kunihiko Takeyama, MD, PhD, Chunyan He, Katherine Kreinbrink, Margaret A. Shipp, MD

Blood (2005) 106 (11): 2400.

https://doi.org/10.1182/blood.V106.11.2400.2400

Published: 2005

Journal Articles

Imatinib Mesylate Induced Fatal Hepatitis B Virus (HBV) Reactivation in a Patient with CML.

Tatsuyuki Kai, MD, PhD, Kazuhiko Ikeda, MD, PhD, Yutaka Shiga, MD, PhD, Hideo Kimura, MD, PhD, Hideyoshi Noji, MD, PhD, Kazuei Ogawa, MD, PhD, Kunihiko Takeyama, MD, PhD, Yukio Maruyama, MD, PhD

Blood (2004) 104 (11): 4677.

https://doi.org/10.1182/blood.V104.11.4677.4677

Published: 2004

NARROW

A Structural Basis for p53-Deficiency, Deregulated Cell Cycle and Unfavorable Outcome in Diffuse Large B-Cell Lymphoma

Mir-15a/16-1 Cluster Is Frequently Deleted In Primary Hodgkin Lymphoma and Modulates Multiple Survival Pathways Including AP-1

Integrative Analysis Reveals Multiple Alterations of p53 Signaling Pathway Components In Primary Diffuse Large B-Cell Lymphomas

Expression and Targeted Inhibition of the Immunoregulatory Carbohydrate-Binding Lectin, Galectin 1, in EBV-Driven Post-Transplant Lymphoproliferative Disorders.

Phase II Study of Chemotherapy (Cx) and Stem Cell Transplantation (SCT) for Adult Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphoma (LBL): Long-Term Follow-up Results of Japan Clinical Oncology Group (JCOG) Study 9402.

Selective Expression of the Immunoregulatory Lectin, Galectin-1, in Precursor B Cell Acute Lymphoblastic Leukemias (ALLs) with MLL Rearrangements

Hodgkin’s Lymphoma Reed Sternberg Cells over Express the T-Cell Inhibitory Carbohydrate-Binding Lectin, Galectin 1: Role of AP-1 and Likely Mechanism of Tumor Immune Escape.

B-Aggressive Lymphoma (BAL) Family Proteins Have Unique Domains Which Modulate Transcription and Exhibit PARP Activity.

Imatinib Mesylate Induced Fatal Hepatitis B Virus (HBV) Reactivation in a Patient with CML.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only